Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SYNAPTIC PLASTICITY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
SYNAPTIC PLASTICITY is a concept in neurodegeneration research. Key relationships include: co discussed, associated with, regulates. Associated with ALZHEIMER, ALZHEIMER'S, ALZHEIMER'S DISEASE. Connected to 54 entities in the SciDEX knowledge graph.
| Name | SYNAPTIC PLASTICITY |
| Key Genes/Proteins | LRP1, NMDAR, CYP46A1 |
| Related Diseases | EXCITOTOXICITY, DEPRESSION, AGING |
| Linked Hypotheses | 6 hypotheses |
Knowledge base pages for this entity
graph TD
SYNAPTIC_PLASTICITY["SYNAPTIC PLASTICITY"]
SYNAPTIC_PLASTICITY -->|"interacts"| Complement["Complement"]
SYNAPTIC_PLASTICITY -->|"interacts"| Nf__b["Nf-Kappab"]
BDNF["BDNF"] -->|"regulates"| SYNAPTIC_PLASTICITY
physical_exercise["physical exercise"] -->|"regulates"| SYNAPTIC_PLASTICITY
APOE4["APOE4"] -->|"inhibits"| SYNAPTIC_PLASTICITY
TrkB_FL["TrkB-FL"] -->|"regulates"| SYNAPTIC_PLASTICITY
PI3K_AKT["PI3K/AKT"] -->|"regulates"| SYNAPTIC_PLASTICITY
PI3K_AKT_pathway["PI3K/AKT pathway"] -->|"regulates"| SYNAPTIC_PLASTICITY
SXD["SXD"] -->|"activates"| SYNAPTIC_PLASTICITY
epigenetic_alterations["epigenetic alterations"] -->|"regulates"| SYNAPTIC_PLASTICITY| Target | Relation | Type | Str |
|---|---|---|---|
| EXCITOTOXICITY | causes | phenotype | 0.70 |
| DEPRESSION | treats | disease | 0.70 |
| LRP1 | protects_against | gene | 0.70 |
| AGING | stabilizes | phenotype | 0.70 |
| NMDAR | activates | gene | 0.70 |
| CYP46A1 | stabilizes | gene | 0.70 |
| CYP46A1 | treats | gene | 0.70 |
| CYP46A1 | protects_against | gene | 0.70 |
| CYP46A1 | inhibits | gene | 0.70 |
| BDNF | treats | gene | 0.65 |
| CA1 | causes | brain_region | 0.65 |
| COGNITIVE DECLINE | regulates | phenotype | 0.65 |
| SEMAGLUTIDE | activates | drug | 0.65 |
| BDNF | targets | gene | 0.65 |
| MINOCYCLINE | activates | drug | 0.65 |
| CREB1 | interacts_with | gene | 0.65 |
| CANCER | implicated_in | disease | 0.60 |
| NMDAR | implicated_in | gene | 0.60 |
| SYNAPTIC TRANSMISSION | implicated_in | phenotype | 0.60 |
| LONG-TERM DEPRESSION | activates | phenotype | 0.60 |
| LONG-TERM DEPRESSION | treats | phenotype | 0.60 |
| OXIDATIVE PHOSPHORYLATION | implicated_in | pathway | 0.55 |
| NEUROGENESIS | associated_with | process | 0.50 |
| BRAINSTEM | associated_with | brain_region | 0.50 |
| PI3K/AKT PATHWAY | associated_with | pathway | 0.50 |
| DENTATE GYRUS | associated_with | brain_region | 0.50 |
| BDNF/TRKB SIGNALING | associated_with | pathway | 0.50 |
| AMYGDALA | associated_with | brain_region | 0.50 |
| CA3 | associated_with | brain_region | 0.50 |
| METFORMIN | associated_with | drug | 0.50 |
| ENTORHINAL CORTEX | associated_with | brain_region | 0.50 |
| INSULIN SIGNALING | associated_with | pathway | 0.50 |
| CALCIUM SIGNALING | associated_with | pathway | 0.50 |
| LIPID RAFT | associated_with | organelle | 0.50 |
| MELATONIN | associated_with | drug | 0.45 |
| WNT SIGNALING | associated_with | pathway | 0.45 |
| CEREBRAL CORTEX | associated_with | brain_region | 0.45 |
| CORTEX | associated_with | brain_region | 0.45 |
| CA1 | associated_with | brain_region | 0.45 |
| BERBERINE | associated_with | drug | 0.45 |
| NLRP3 INFLAMMASOME | associated_with | pathway | 0.45 |
| PREFRONTAL CORTEX | associated_with | brain_region | 0.45 |
| BASAL GANGLIA | associated_with | brain_region | 0.45 |
| QUERCETIN | associated_with | drug | 0.45 |
| DASATINIB | associated_with | drug | 0.45 |
| HIPPOCAMPUS | associated_with | brain_region | 0.45 |
| CAMP SIGNALING | associated_with | pathway | 0.45 |
| SEMAGLUTIDE | associated_with | drug | 0.45 |
| MINOCYCLINE | associated_with | drug | 0.45 |
| STRIATUM | associated_with | brain_region | 0.45 |
| Source | Relation | Type | Str |
|---|---|---|---|
| RELN | regulates | entity | 0.95 |
| NEURON | activates | cell_type | 0.95 |
| PGC1A | regulates | entity | 0.85 |
| MAP6 | involved_in | entity | 0.80 |
| LIPID METABOLISM | contributes_to | entity | 0.80 |
| CA1 | regulates | brain_region | 0.70 |
| CREB | stabilizes | gene | 0.70 |
| ALS | stabilizes | disease | 0.70 |
| CA1 | treats | brain_region | 0.70 |
| HDAC3 | activates | gene | 0.70 |
| FOXO3 | inhibits | gene | 0.70 |
| DNMT1 | protects_against | gene | 0.70 |
| CHOLESTEROL | stabilizes | phenotype | 0.70 |
| DENTATE GYRUS | activates | brain_region | 0.70 |
| NEUROINFLAMMATION | destabilizes | phenotype | 0.70 |
| INTERNEURONS | inhibits | cell_type | 0.70 |
| INTERNEURONS | produces | cell_type | 0.70 |
| INTERNEURONS | protects_against | cell_type | 0.70 |
| INTERNEURONS | activates | cell_type | 0.70 |
| NEURONS | treats | cell_type | 0.70 |
| CHOLESTEROL | inhibits | phenotype | 0.70 |
| APP | inhibits | gene | 0.66 |
| MICROGLIA | mediates | entity | 0.65 |
| NEURON | interacts_with | cell_type | 0.65 |
| NEURONS | interacts_with | cell_type | 0.65 |
| HDAC3 | treats | gene | 0.65 |
| ASTROCYTE | treats | cell_type | 0.65 |
| BDNF | causes | gene | 0.65 |
| GLIOSIS | inhibits | phenotype | 0.65 |
| NEURONS | exacerbates | cell_type | 0.65 |
| BDNF | stabilizes | gene | 0.65 |
| MULTIPLE SCLEROSIS | stabilizes | disease | 0.65 |
| MELATONIN | inhibits | drug | 0.65 |
| NLRP3 INFLAMMASOME | treats | pathway | 0.65 |
| COGNITIVE DECLINE | regulates | phenotype | 0.65 |
| OXIDATIVE STRESS | activates | phenotype | 0.65 |
| SIRT1 | regulates | gene | 0.65 |
| APP | treats | gene | 0.65 |
| NEUROFIBRILLARY TANGLES | causes | phenotype | 0.65 |
| GLUTAMATE | regulates | phenotype | 0.65 |
| COGNITIVE DECLINE | activates | phenotype | 0.65 |
| NTRK2 | regulates | gene | 0.65 |
| MICROGLIA | degrades | cell_type | 0.65 |
| TAU | inhibits | protein | 0.65 |
| COGNITIVE DECLINE | treats | phenotype | 0.65 |
| PARKINSON'S DISEASE | treats | disease | 0.65 |
| TDP-43 | activates | gene | 0.65 |
| TDP-43 | treats | gene | 0.65 |
| NEURON | produces | cell_type | 0.65 |
| CDK5 | activates | gene | 0.65 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Sleep Spindle-Synaptic Plasticity Enhancement | 0.491 | neurodegeneration | Sleep disruption as cause and consequenc |
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Effects of caffeine on sleep and cognition. [PMID:21531247] | Snel J, Lorist MM | Prog Brain Res | 2011 | 1 |
| Functional dissection of Timekeeper (Tik) implicates opposite roles for CK2 and [PMID:19536808] | Kunttas-Tatli E, Bose A, Kahali B, Bisho | Genesis | 2009 | 1 |
| CI-994 is a dual modulator of class I HDACs and Wnt/β-catenin signaling for the [PMID:41654970] | Lu W, Kawatani K, Ren Y | Alzheimers Res Ther | 2026 | 0 |
| Molecular brake on firing pattern transitions in MHbChAT neurons to mediate nico [PMID:41903536] | Zheng ZW, Min PX, Luo YL, Mao XF, Zhang | Neuron | 2026 | 0 |
| Presynaptic P/Q calcium channel deficit promotes postsynaptic excitability remod [PMID:41932329] | Thompson SJ, Miao QL, Sonig A, Noebels J | Neuron | 2026 | 0 |
| Estradiol modulates neuronal network hyperexcitability in select NDD risk genes. [PMID:41757108] | Pruitt A, Yang L, Lee S, Balafkan N, Sea | bioRxiv : the preprint server | 2026 | 0 |
| Vitamin D supplementation and COVID-19 risk: a population-based, cohort study. [PMID:34273098] | ["Oristrell J", "Oliva J", "Casado E", " | Journal of endocrinological in | 2022 | 0 |
| Intracellular calcium homeostasis and its dysregulation underlying epileptic sei [PMID:36403388] | Zhou X, Chen Z, Xiao L, Zhong Y, Liu Y, | Seizure | 2022 | 0 |
| Homeostatic plasticity and burst activity are mediated by hyperpolarization-acti [PMID:33547341] | Rátkai A, Tárnok K, Aouad HE, Micska B, | Scientific reports | 2021 | 0 |
| Machine learning reveals bilateral distribution of somatic L1 insertions in huma [PMID:33432196] | ["Zhu X", "Zhou B", "Pattni R", "Gleason | Nature neuroscience | 2021 | 0 |
| Cryo-EM structures of full-length Tetrahymena ribozyme at 3.1 Å resolution. [PMID:34381213] | ["Su Z", "Zhang K", "Kappel K", "Li S", | Nature | 2021 | 0 |
| Prevalence and follow-up of potentially inappropriate medication and potentially [PMID:32641251] | ["van Loveren F", "van Berlo-van de Laar | Journal of geriatric oncology | 2021 | 0 |
| Neuronal Cav3 channelopathies: recent progress and perspectives. [PMID:32638069] | Lory P, Nicole S, Monteil A | Pflugers Archiv : European jou | 2020 | 0 |
| Single-cell epigenomic analyses implicate candidate causal variants at inherited [PMID:33106633] | ["Corces M", "Shcherbina A", "Kundu S", | Nature genetics | 2020 | 0 |
| Reciprocal associations between depression, anxiety and work-related injury. [PMID:31685530] | ["Gerasimaviciute V", "B\u00fcltmann U", | Injury prevention : journal of | 2020 | 0 |
| On-surface synthesis of planar dendrimers via divergent cross-coupling reaction. [PMID:31160575] | ["Li D", "Li S", "Xie Y", "Hua X", "Long | Nature communications | 2019 | 0 |
| STAT4 Directs a Protective Innate Lymphoid Cell Response to Gastrointestinal Inf [PMID:31562212] | ["Dulson S", "Watkins E", "Crossman D", | Journal of immunology (Baltimo | 2019 | 0 |
| Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of ep [PMID:29728119] | ["Ayg\u00f6ren-P\u00fcrs\u00fcn E", "Mag | Orphanet journal of rare disea | 2018 | 0 |
| Predictors of Extended Length of Hospital Stay Following Surgical Repair of Cong [PMID:30171266] | ["Azhar A", "Aljefri H"] | Pediatric cardiology | 2018 | 0 |
| Interstitial lung abnormalities and self-reported health and functional status. [PMID:29317545] | ["Axelsson G", "Putman R", "Araki T", "S | Thorax | 2018 | 0 |